Patents Assigned to AesculaTech, Inc.
  • Patent number: 12440373
    Abstract: Described herein is a generalized injection device for delivering formulations of various mechanical properties to precise locations. Of particular interest is the manifestation intended for the application of a thermally responsive hydrogel to the tear duct for the purpose of occlusion, as a treatment for symptoms associated with dry eye syndrome. Further, a modular solution to the need for an injection device across a variety of applications, mechanism, and physical considerations is provided. This disclosure provides examples of methods for precise injection of low volumes, moisture retention in pre-filled injection devices, and actuation for automatic or manual injection, to name a few.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: October 14, 2025
    Assignee: AESCULATECH, INC.
    Inventors: Niki Bayat, Adam Griese, Roby Menefee, Rahul Janardhanan, Jose Ramirez
  • Patent number: 11400044
    Abstract: Compositions, methods, and kits for treating dry eye and related diseases are provided. In one aspect, the present disclosure relates to administering thermoresponsive polymeric compositions to the tear duct of the subject. Administering a thermoresponsive polymeric composition to the tear duct of the subject may be useful in treating dry eye and related conditions.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: August 2, 2022
    Assignee: AesculaTech, Inc.
    Inventors: Andrew Bartynski, Niki Bayat